/
Markets
Crypto
News
Forecasts
Forex Brokers
Calendars
Macro Data
About us
Commodity Prices
Currency Rates
Cryptocurrency Prices
Global Market Indices
Stock Prices
ETF Prices
Cryptocurrency Prices
Crypto Exchanges
Crypto Wallets
Cryptocurrency News
Cryptocurrency Forecasts
Commodity News
Forex News
Crypto News
Stock Market News
Economic News
Opinions
Broker News
Commodities
Forex
Crypto
Indices
Natural Gas Forecasts
Gold Forecasts
WTI Crude Oil Forecasts
S&P 500 Forecasts
Forex Brokers Reviews
Best Brokers Guides
Compare Forex Brokers
Best Forex Brokers
Best Forex Platforms
Best MT4 Brokers
Best for Trading Gold
Best Brokers in Australia
Best Brokers for Beginners
Best Brokers in UK
Brokers Promotions
Stock Brokers
Economic Calendar
Earnings Calendar
Splits Calendar
Dividends Calendar
Holiday Calendar
IPO Calendar
Stock Screener
Currency Converter
Global Macro indicators
Sovereign Credit Ratings
Global Major Indicators
Interest Rates
United States Indicators
China Indicators
Australia Indicators
Euro Area Indicators
About us
Contact Us
Terms Of Use
Become A Contributer
EUR/USD
+0.34%
Natural Gas
+0.34%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.46%
VIX
N/A
Economic Calendar
EUR/USD
+0.34%
Natural Gas
+0.34%
Gold
N/A
BTC
N/A
ETH
N/A
SPX
-0.46%
VIX
N/A
Economic Calendar
BTC
N/A
ETH
N/A
XRP
N/A
ADA
N/A
SOL
N/A
Review
Review
Review
Bank of Japan Monetary Policy Decision Sends the USD/JPY to 156
about 3 hours ago
Tech Giants Excel: Alphabet’s Dividend, Microsoft’s AI Growth, Snap’s Q1 Surge
about 10 hours ago
Microsoft and Alphabet Bracing for Key Earnings Release
about 12 hours ago
Pending Home Sales Increased 3.4% In March, Beating Analyst Expectations
about 17 hours ago
US GDP Growth Starts 2024 Below Expectations
about 17 hours ago
German GfK Consumer Climate Indicator Climbs to -24.2 for May
1 day ago
Gold (XAU) Daily Forecast: XAU Nears $2,335; More Upside Ahead?
34 minutes ago
Natural Gas and Oil Forecast: Tensions Spike Prices; Will Oil Stay Bullish?
about 1 hour ago
DAX Index Today: ECB Chatter, Corporate Earnings and US Inflation
about 3 hours ago
Bitcoin (BTC) News Today: Analyzing BTC-Spot ETF Flows Amid US Economic Reports
about 3 hours ago
XRP News Today: SEC Given Three Days to Counter Ripple’s Motion to Strike
about 1 hour ago
AUD to USD Forecast: Aussie Inflation Data Pivotal for RBA Interest Rate Outlook
about 8 hours ago
Quick Links
:
Forecasts
Economic Calendar
Commodities
Trade Now
ad
ad
Advertisement
Advertisement
home
stocks
INCY
profile
Incyte Corp.
Follow
INCY
(
Nasdaq - US
)
N/A
51.16
-0.58 (-1.12%)
in
:
usd
•
As of: Apr 25, 2024 15:59
UTC -4
Open
51.85
High
51.85
Low
50.36
Overview
News & Analysis
Profile
Financials
Advanced Chart
History
Earnings
About
Incyte Corp.
CEO
Herv¿ Hoppenot
Headquarters
1801 augustine cut-off
wilmington, de 19803, united states
Auditor
Ernst & Young LLP
Employees
2,524
Share Holders
112
Website
www.incyte.com
Industry
pharmaceuticals major
Sector
health technology
Company Overview
Incyte Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. The company conducts its European clinical development operations in Geneva, Switzerland. Incyte's lead drug, Jakafi (ruxolitinib), is a first-in-class JAK1/JAK2 inhibitor, approved in the United States for the treatment of patients with polycythemia vera ('PV'),who have had an inadequate response to or are intolerant to hydroxyurea. It is also approved for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-PV MF, and post-essential thrombocythemia MF. The drug is also approved in the United States for treatment of steroid-refractory acute graft-versus-host disease (GVHD) in adult and pediatric patients aged 12 years or older.
Incyte Corp.
Statistics
Valuation Measures
Market Capitalization
2
11.49B
Enterprise Value
8.31B
Enterprise Value/EBITDA
(ttm)
11.81
Price to Earnings Ratio
(ttm)
19.27
Price to Book
(mrq)
2.23
Price to Sales
(ttm)
3.14
Price to Cash
(ytd)
21.21
Profitability
Gross Margin
(ttm)
93.10%
Operating Margin
(ttm)
16.42%
Profit Margin
(ttm)
15.62%
Return on Equity
(ttm)
12.56%
Return on Invested Capital
(ttm)
12.06%
Return on Assets
(ttm)
9.64%
Income Statement
Revenue
(ttm)
3.70B
Revenue Per Share
(ttm)
16.46
Gross Profit
(ttm)
3.44B
EBITDA
(ttm)
3
703.19M
Net Income Avi to Common
(ttm)
597.60M
Diluted EPS
(ttm)
2.65
Share Statistics
Beta (5Y Monthly)
0.65
52-Week Change
-30.42%
S&P500 52-Week Change
24.47%
S&P500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding
1
224.53M
Dividend Yield
0.00%
Float
4
185.23M
%
Held by Insiders
17.50%
%
Held by Institutions
96.97%
Balance Sheet
Total Cash
(mrq)
3.66B
Total Cash Per Share
(mrq)
16.28
Total Debt
(mrq)
32.60M
Total Debt/Equity
(mrq)
0.63%
Current Ratio
(mrq)
3.75%
Quick Ratio
(mrq)
3.36%
Book Value Per Share
(mrq)
23.14
Cash Flow
Operating Cash Flow Per Share
(ytd)
2.20
Free Cash Flow
(ytd)
464.00M
Table Key
mrq
=
Most Recent Quarter
ttm
=
Trailing Twelve Months
ytd
=
Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.
1
Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2
Market Cap is calculated using total shares outstanding and the most recent share price.
3
EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4
The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Sponsored
Sponsored
This Section / Page contains links to the 3rd party websites of our top partners from whom we may receive compensation.
Trade With A Regulated Broker